Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000027

CFO and Secretary sold 96,815 shares at $12.94 ($1,252,718)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Levy Adam Scott CFO and Secretary 2024-06-11 Sale 10b5-1 −96,815 $12.94 $1,252,718 255,462 D
Open-market sales · 96,815 sh · avg $12.94 · $1,252,718
Loading xslF345X05/wk-form4_1718314405.xml…